Consequently, we identified that nine oncogenes or tumor driver genes—CD81, EIF4A1, KDM1A, MAOA, METTL3, PDGFB, STEAP1, STEAP2, and TRIM28—were upregulated in FOXA1 mutant prostate cancer (Figure 5B). The gene discussed is METTL3; the disease is prostate carcinoma.